celecoxib has been researched along with Cataract, Membranous in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Both rofecoxib and celecoxib were effective at inhibiting PCO formation in our ex vivo model." | 1.34 | Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition. ( Barden, CA; Chandler, HL; Colitz, CM; Kusewitt, DF; Lu, P, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chandler, HL | 1 |
Barden, CA | 1 |
Lu, P | 1 |
Kusewitt, DF | 1 |
Colitz, CM | 1 |
1 other study available for celecoxib and Cataract, Membranous
Article | Year |
---|---|
Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
Topics: Animals; Apoptosis; Biomarkers; Cataract; Celecoxib; Cell Differentiation; Cell Movement; Cell Proli | 2007 |